MEDICINE, cilt.96, sa.34, 2017 (SCI İndekslerine Giren Dergi)
Rationale: Tamoxifen has been used in women with hormone receptor-positive breast cancer and has been shown to successfully reduce both recurrence and mortality. On the contrary, long-term use of tamoxifen has hormone-related urogenital side effects which decrease the quality of life of the patients.